Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0034 | 0.0034 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0034 | 0.0034 |
Onchocerca volvulus | 0.0033 | 0.0677 | 0.1373 | |
Onchocerca volvulus | 0.0058 | 0.1623 | 0.3293 | |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0119 | 0.0119 |
Brugia malayi | hypothetical protein | 0.0123 | 0.4008 | 0.4008 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0267 | 0.9332 | 0.9332 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0016 | 0.0056 | 0.0056 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0267 | 0.9332 | 0.9332 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.4929 | 0.4929 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0016 | 0.0056 | 0.0056 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0677 | 0.0677 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0056 | 0.0056 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0677 | 0.0677 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.4789 | 0.4789 |
Schistosoma mansoni | lamin | 0.0033 | 0.0677 | 0.0725 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0017 | 0.0119 | 0.0119 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.4929 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0677 | 0.0677 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0677 | 0.0677 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0677 | 0.0677 |
Echinococcus granulosus | lamin | 0.0033 | 0.0677 | 0.0677 |
Schistosoma mansoni | lamin | 0.0033 | 0.0677 | 0.0725 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0677 | 0.0677 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.4929 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1623 | 0.1623 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1623 | 0.1739 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0677 | 0.0677 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0677 | 0.0677 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0677 | 0.0677 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.4789 | 0.4789 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0677 | 0.0725 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0677 | 0.0677 |
Brugia malayi | hypothetical protein | 0.0148 | 0.4929 | 0.4929 |
Onchocerca volvulus | 0.0033 | 0.0677 | 0.1373 | |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0267 | 0.9332 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1623 | 0.1739 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0655 | 0.0655 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0267 | 0.9332 | 0.9332 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.4929 | 0.4929 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.4789 | 0.4789 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.7943 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.122 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.5849 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.